HILS - Hillstream BioPharma Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2026-02-05)
Last
 3.93		 Change
 ⇓ -0.80   (-16.91%)		 Volume
  1,364,898
Open
 4.35		 High
 4.49		 Low
 3.85
8EMA (Daily)
 4.41		 40EMA (Daily)
 3.43		 50EMA (Daily)
 3.32		 STO (Daily)
 74.616		 MACD Hist (Daily)
 0.047
8EMA (Weekly)
 3.442		 40EMA (Weekly)
 2.75		 50EMA (Weekly)
 2.64		 STO (Weekly)
 27.983		 MACD Hist (Weekly)
 0.174
Company Profile
Hillstream BioPharma Inc is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com